Most of our time this week was spent covering a sweeping, long-shot bid to legalize cannabis from Sens. Chuck Schumer, Cory Booker and Ron Wyden. The trio introduced a draft version of the bill, The Cannabis Administration and Opportunity Act (CAOA), on Wednesday.
Psyched: Nasdaq Gets Its Third Psychedelics Company , Mynd Goes Public, Delic Buys New Research Facility
The Nasdaq welcomed its third psychedelics company this week, with the acquisition of MagicMed Industries by Enveric Biosciences ENVB -1.01% in an all-stock deal. “It’s a really exclusive group listed on the Nasdaq, and that access to capital is going to be a game-changer for everybody,” MagicMed’s CEO and president Dr. Joseph Tucker told Benzinga.
New Psychedelic Company Combines Neuroscience & Ceremonial Healing
Dimensions Health Centres (“Dimensions”), a psychedelic treatment company, officially announced the company formation and subsequent closure of an initial, oversubscribed round of funding. The management team is led by CEO and Co-Founder Christopher Dawson, COO and co-founder Andrew Galloway, and Chairperson and Co-Founder David Eden.